Showing 13–24 of 112 results

Cometriq 80 mg Alternative – Caboxen (Cabozantinib) 80 mg Capsule | Everest Pharmaceuticals

Caboxen 80 mg (Cabozantinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Cometriq (Exelixis). It belongs to the multikinase inhibitor class and is used in selected medullary thyroid cancer settings for capsule formulations; other cabozantinib formulations have different approved uses.

Active ingredient: Cabozantinib
Strength: 80 mg
Form: Capsule
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Doptelet 20 mg Alternative – Avapag (Avatrombopag) 20 mg Tablet | Everest Pharmaceuticals

Avapag 20 mg (Avatrombopag) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Doptelet (Sobi / Dova). It belongs to the thrombopoietin receptor agonist class and is used in selected thrombocytopenia associated with chronic liver disease procedures or immune thrombocytopenia.

Active ingredient: Avatrombopag
Strength: 20 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Erleada 60 mg Alternative – Apaluda (Apalutamide) 60 mg Tablet | Beacon Pharmaceuticals

Apaluda 60 mg (Apalutamide) Tablet by Beacon Pharmaceuticals. Reference brand: Erleada. androgen receptor inhibitor; used in selected advanced prostate cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Erleada 60 mg Alternative – Prostaxen (Apalutamide) 60 mg Tablet | Everest Pharmaceuticals

Prostaxen 60 mg (Apalutamide) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Erleada (Janssen). It belongs to the androgen receptor inhibitor class and is used in selected castration-resistant or castration-sensitive prostate cancer settings.

Active ingredient: Apalutamide
Strength: 60 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Evrenzo 100 mg Alternative – Renofix (Roxadustat) 100 mg Tablet | Everest Pharmaceuticals

Renofix 100 mg (Roxadustat) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Evrenzo (Astellas). It belongs to the HIF-prolyl hydroxylase inhibitor class and is used in anemia associated with chronic kidney disease in jurisdictions where authorized.

Active ingredient: Roxadustat
Strength: 100 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Evrenzo 20 mg Alternative – Renofix (Roxadustat) 20 mg Tablet | Everest Pharmaceuticals

Renofix 20 mg (Roxadustat) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Evrenzo (Astellas). It belongs to the HIF-prolyl hydroxylase inhibitor class and is used in anemia associated with chronic kidney disease in jurisdictions where authorized.

Active ingredient: Roxadustat
Strength: 20 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Evrenzo 50 mg Alternative – Renofix (Roxadustat) 50 mg Tablet | Everest Pharmaceuticals

Renofix 50 mg (Roxadustat) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Evrenzo (Astellas). It belongs to the HIF-prolyl hydroxylase inhibitor class and is used in anemia associated with chronic kidney disease in jurisdictions where authorized.

Active ingredient: Roxadustat
Strength: 50 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Evrenzo 70 mg Alternative – Renofix (Roxadustat) 70 mg Tablet | Everest Pharmaceuticals

Renofix 70 mg (Roxadustat) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Evrenzo (Astellas). It belongs to the HIF-prolyl hydroxylase inhibitor class and is used in anemia associated with chronic kidney disease in jurisdictions where authorized.

Active ingredient: Roxadustat
Strength: 70 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Exjade 250 mg Alternative – Deferox (Deferasirox) 250 mg Tablet | Beacon Pharmaceuticals

Deferox 250 mg (Deferasirox) Tablet by Beacon Pharmaceuticals. Reference brand: Exjade. oral iron chelator; used in chronic iron overload requiring chelation. Prescription medicine. Brand comparison does not establish interchangeability.

Exjade 500 mg Alternative – Deferox (Deferasirox) 500 mg Tablet | Beacon Pharmaceuticals

Deferox 500 mg (Deferasirox) Tablet by Beacon Pharmaceuticals. Reference brand: Exjade. oral iron chelator; used in chronic iron overload requiring chelation. Prescription medicine. Brand comparison does not establish interchangeability.

Femara 2.5 mg Alternative – Femroz (Letrozole) 2.5 mg | Everest Pharmaceuticals

$500.00

Femroz 2.5 mg by Everest Pharmaceuticals Ltd., Bangladesh, contains letrozole 2.5 mg, the same active ingredient and strength as the originator brand Femara 2.5 mg (Novartis). It is a prescription aromatase inhibitor used in the hormonal treatment of certain breast cancers in postmenopausal women.

Originator reference: Femara (Novartis)
Listed alternative brand: Femroz (Everest Pharmaceuticals)
Generic: Letrozole 2.5 mg
Form: Oral tablet
Prescription: Required

Shared ingredients and strength do not establish bioequivalence or automatic interchangeability. Any substitution must be approved by a qualified healthcare professional.

Femara 2.5 mg Alternative – Lexel (Letrozole) 2.5 mg Tablet | Beacon Pharmaceuticals

Lexel 2.5 mg (Letrozole) Tablet by Beacon Pharmaceuticals. Reference brand: Femara. aromatase inhibitor; used in selected hormone receptor-positive breast cancer. Prescription medicine. Brand comparison does not establish interchangeability.